Clinical trial

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

NCT04396873

Study summary

ClinicalTrials.gov

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention 11C-MC1 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 11C-PS13 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 18f-florbetaben Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2021-08-17

PhasePHASE1

Conditions

Parkinson's Diseaseverified · MONDO: Parkinson disease

Dementiaverified · MONDO: dementia

Alzheimer's Diseaseverified · MONDO: Alzheimer disease

ALSverified · MONDO: amyotrophic lateral sclerosis

Mild Cognitive Impairmentunresolved

Interventions

11C-MC1DRUG

11C-PS13DRUG

18f-florbetabenDRUG

Sponsors & collaborators

National Institute of Mental Health (NIMH)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04396873 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.